Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Harvard Apparatus Regenerative Technology, Inc. (HRGN : OTC)

• Company Description    Harvard Apparatus Regenerative Technology Inc. provide greater clarity and visibility for its regenerative technology and expanding strategy on rejuvenation. Harvard Apparatus Regenerative Technology Inc., formerly known as Biostage Inc., is based in HOLLISTON, Mass. Number of Employees: 8

• Price / Volume Information    Yesterday's Closing Price: $1.84 Daily Weekly Monthly 20 Day Moving Average: 7,866 shares Shares Outstanding: 17.17 (millions) Market Capitalization: $31.59 (millions) Beta: -0.22 52 Week High: $2.92 52 Week Low: $0.94 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 11.52% 11.70% 12 Week -10.68% -12.12% Year To Date 0.00% 0.00%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 84 October Hill Road Suite 11 - Holliston,MA 01746 USA ph: 774-233-7300 fax: 774-233-7302 jdamasio@hregen.com http://www.hregen.com

• General Corporate Information    Officers Junli (Jerry) He - Chief Executive Officer; Director; and Chairman Jason Jing Chen - Vice Chairman Joseph Damasio Jr. - Chief Financial Officer David Green - Director Ting Li - Director Peer Information Harvard Apparatus Regenerative Technology, Inc. (CHCR) Harvard Apparatus Regenerative Technology, Inc. (ESRX) Harvard Apparatus Regenerative Technology, Inc. (MYDP) Harvard Apparatus Regenerative Technology, Inc. (COR) Harvard Apparatus Regenerative Technology, Inc. (GBCS) Harvard Apparatus Regenerative Technology, Inc. (LAXAF) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: Medical Services Sector: Medical CUSIP: 09074M202 SIC: 3841 Fiscal Year Fiscal Year End: December Last Reported Quarter: 09/01/25 Next Expected EPS Date: 02/06/26 Share - Related Items Shares Outstanding: 17.17 Most Recent Split Date: 12.00 (0.05:1) Beta: -0.22 Market Capitalization: $31.59 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 02/06/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 20.33 Price/Cash Flow: - Price / Sales: 42.52 EPS Growth vs. Year Ago Period: 16.67% vs. Previous Quarter: 9.09% Sales Growth vs. Year Ago Period: 108.47% vs. Previous Quarter: -61.20% ROE 12/31/25 - - 09/30/25 - -344.15 06/30/25 - -270.93 ROA 12/31/25 - - 09/30/25 - -208.17 06/30/25 - -174.74 Current Ratio 12/31/25 - - 09/30/25 - 1.86 06/30/25 - 0.91 Quick Ratio 12/31/25 - - 09/30/25 - 1.83 06/30/25 - 0.89 Operating Margin 12/31/25 - - 09/30/25 - -878.33 06/30/25 - -984.68 Net Margin 12/31/25 - - 09/30/25 - -878.33 06/30/25 - -984.68 Pre-Tax Margin 12/31/25 - - 09/30/25 - -878.33 06/30/25 - -984.68 Book Value 12/31/25 - - 09/30/25 - 0.09 06/30/25 - 0.04 Inventory Turnover 12/31/25 - - 09/30/25 - 14.06 06/30/25 - 8.66 Debt-to-Equity 12/31/25 - - 09/30/25 - 0.00 06/30/25 - 0.00 Debt-to-Capital 12/31/25 - - 09/30/25 - 0.00 06/30/25 - 0.00

Powered by Zacks Investment Research ©